In the latest session, Atyr Pharma Inc (NASDAQ: LIFE) closed at $1.59 down -4.22% from its previous closing price of $1.66. In other words, the price has decreased by -$0.0700 from its previous closing price. On the day, 749995 shares were traded. LIFE stock price reached its highest trading level at $1.7200 during the session, while it also had its lowest trading level at $1.5750.
Ratios:
For a deeper understanding of Atyr Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.33 and its Current Ratio is at 8.33. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.14.
On October 12, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $22.
On September 21, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $19.Piper Sandler initiated its Overweight rating on September 21, 2021, with a $19 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 06 ’24 when Broadfoot Jill Marie sold 1,590 shares for $1.69 per share. The transaction valued at 2,687 led to the insider holds 20,821 shares of the business.
Shukla Sanjay bought 12,000 shares of LIFE for $14,136 on Dec 12 ’23. The President and CEO now owns 106,173 shares after completing the transaction at $1.18 per share. On Dec 11 ’23, another insider, Shukla Sanjay, who serves as the President and CEO of the company, bought 3,000 shares for $1.17 each. As a result, the insider paid 3,510 and bolstered with 94,173 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIFE now has a Market Capitalization of 93.11M and an Enterprise Value of 6.20M. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.67 while its Price-to-Book (P/B) ratio in mrq is 0.95. Its current Enterprise Value per Revenue stands at 0.58 whereas that against EBITDA is -0.14.
Stock Price History:
Over the past 52 weeks, LIFE has reached a high of $2.70, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 1.6905, while the 200-Day Moving Average is calculated to be 1.6942.
Shares Statistics:
For the past three months, LIFE has traded an average of 593.02K shares per day and 759.87k over the past ten days. A total of 58.56M shares are outstanding, with a floating share count of 56.48M. Insiders hold about 3.56% of the company’s shares, while institutions hold 69.93% stake in the company. Shares short for LIFE as of Feb 15, 2024 were 135.28k with a Short Ratio of 0.23, compared to 177.45k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.23% and a Short% of Float of 0.34%.
Earnings Estimates
There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.21 and a low estimate of -$0.28, while EPS last year was -$0.26. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.18 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.91 and -$0.97 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$0.85, with 5 analysts recommending between -$0.56 and -$0.99.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for LIFE’s current fiscal year. The highest revenue estimate was $600k, while the lowest revenue estimate was $350k, resulting in an average revenue estimate of $410k. In the same quarter a year ago, actual revenue was $10.39M, down -96.10% from the average estimate.
